DK1272642T3 - Kaffemannase - Google Patents

Kaffemannase

Info

Publication number
DK1272642T3
DK1272642T3 DK01933654T DK01933654T DK1272642T3 DK 1272642 T3 DK1272642 T3 DK 1272642T3 DK 01933654 T DK01933654 T DK 01933654T DK 01933654 T DK01933654 T DK 01933654T DK 1272642 T3 DK1272642 T3 DK 1272642T3
Authority
DK
Denmark
Prior art keywords
coffee
hydrolysis
polysaccharides
genome
reproduced
Prior art date
Application number
DK01933654T
Other languages
English (en)
Inventor
John Rogers
Pierre Marraccini
Raymond David Pridmore
Christof Gysler
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK1272642T3 publication Critical patent/DK1272642T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C12N15/8246—Non-starch polysaccharides, e.g. cellulose, fructans, levans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Tea And Coffee (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK01933654T 2000-03-30 2001-02-13 Kaffemannase DK1272642T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201175A EP1138771A1 (fr) 2000-03-30 2000-03-30 Endo-Mannanase de café
PCT/EP2001/001549 WO2001075084A2 (en) 2000-03-30 2001-02-13 Coffee mannanase

Publications (1)

Publication Number Publication Date
DK1272642T3 true DK1272642T3 (da) 2007-07-02

Family

ID=8171286

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01933654T DK1272642T3 (da) 2000-03-30 2001-02-13 Kaffemannase

Country Status (9)

Country Link
US (2) US7148399B2 (da)
EP (2) EP1138771A1 (da)
JP (1) JP2003529367A (da)
AT (1) ATE360078T1 (da)
DE (1) DE60127950T2 (da)
DK (1) DK1272642T3 (da)
ES (1) ES2283412T3 (da)
PT (1) PT1272642E (da)
WO (1) WO2001075084A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2457821A1 (en) * 2001-10-10 2003-04-24 Societe Des Produits Nestle S.A. Coffee plant with reduced .alpha.-d-galactosidase activity
EP2545166A2 (en) 2010-03-09 2013-01-16 Nestec S.A. Modulation of galactomannan content in coffee
CN107129958B (zh) * 2017-06-09 2021-07-20 华南理工大学 一种β-甘露聚糖酶工程菌的筛选方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334529A (en) 1989-06-27 1994-08-02 Escagenetics Corporation Stably transformed coffee plant cells and plantlets
US6329191B1 (en) * 1993-08-30 2001-12-11 Hawaii Biotechnology Group, Inc. DNA encoding recombinant coffee bean alpha-galactosidase
JP3043560B2 (ja) * 1993-12-27 2000-05-22 キリンビバレッジ株式会社 安定なコーヒー飲料の製造法
ES2137277T3 (es) * 1994-04-07 1999-12-16 Nestle Sa Hidrolisis de cafe, con una beta-mananasa inmovilizada.
US5874269A (en) * 1995-06-07 1999-02-23 University Of Hawaii Purified proteins, recombinant DNA sequences and processes for controlling the ripening of coffee plant
US5778310A (en) 1995-11-30 1998-07-07 Northern Telecom Limited Co-channel interference reduction
GB9524752D0 (en) * 1995-12-04 1996-02-07 Danisco Modification process
CN1183998A (zh) 1997-10-22 1998-06-10 李榕生 紧凑式高效低能耗空气磁力分离技术
WO1999024588A1 (en) * 1997-11-07 1999-05-20 University Of Guelph cDNA CLONE OF ENDO-β-MANNANASE FROM PLANT TISSUES
US6060299A (en) * 1998-06-10 2000-05-09 Novo Nordisk A/S Enzyme exhibiting mannase activity, cleaning compositions, and methods of use
EP2261359B1 (en) * 1998-06-10 2014-08-20 Novozymes A/S Mannanases
EP1123404A2 (en) * 1998-10-13 2001-08-16 Genesis Research & Development Corporation Limited Materials and methods for the modification of plant cell wall polysaccharides
WO2000028046A1 (fr) * 1998-11-11 2000-05-18 Societe Des Produits Nestle S.A. Mannanase de coffea arabica
EP1033405A3 (en) * 1999-02-25 2001-08-01 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
WO2001023530A1 (en) * 1999-09-30 2001-04-05 The Regents Of The University Of California Genes expressed in germinating seeds and their uses

Also Published As

Publication number Publication date
US7148399B2 (en) 2006-12-12
US20070117196A1 (en) 2007-05-24
DE60127950D1 (de) 2007-05-31
WO2001075084A2 (en) 2001-10-11
US7700358B2 (en) 2010-04-20
DE60127950T2 (de) 2008-01-17
EP1272642B1 (en) 2007-04-18
EP1138771A1 (fr) 2001-10-04
PT1272642E (pt) 2007-05-31
WO2001075084A3 (en) 2002-01-10
ATE360078T1 (de) 2007-05-15
EP1272642A2 (en) 2003-01-08
ES2283412T3 (es) 2007-11-01
US20030131380A1 (en) 2003-07-10
JP2003529367A (ja) 2003-10-07

Similar Documents

Publication Publication Date Title
Emori et al. All four repeating domains of the endogenous inhibitor for calcium-dependent protease independently retain inhibitory activity. Expression of the cDNA fragments in Escherichia coli.
IL86480A (en) Recombinant dna coding for human proapolipoprotein a-1,expression vectors containing it and cells transformed by said expression vector
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
UA89944C2 (ru) Продуцирование высокоманнозных белков в растительных культурах
Le Bars et al. Hydrolysis of αs1-casein by bovine plasmin
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
DK1071442T3 (da) Fremgangsmåder og præparater til peptidsyntese (T-20)
ATE268384T1 (de) Analog von haemophilus hin47 mit verminderter protease aktivität
Saraste et al. A gene in Paracoccus for subunit III of cytochrome oxidase
KR910002520B1 (ko) 세포 성장 억제 인자
EP0462065A3 (en) New signal sequences
MOLLAY et al. Isolation of a dipeptidyl aminopeptidase, a putative processing enzyme, from skin secretion of Xenopus laevis
UA122856C2 (uk) Варіантний інсектицидний ген ахмі115 та способи його застосування
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
EP0251730A2 (en) Production of human lysozyme
DK1272642T3 (da) Kaffemannase
ZA200102385B (en) Nucleotide sequences coding for the dapC gene and process for the production of L-lysine.
EP0770137A4 (en) IMPROVEMENTS IN PROTEIN PRODUCTION IN HOST CELLS
ES2127192T3 (es) Polipeptidos especificos del epididimo y su aplicacion.
Gonnelli et al. Purification and characterization of two leaf polypeptide inhibitors of leaf protease from alfalfa (Medicago sativa)
ES2270827T3 (es) Uso de procarboxipeptidasa b pancreatica para la produccion de insulina.
Oda et al. Purification and Characterization of the Active SerineiPyruvate Aminotransferase of Rat Liver Mitochondria Expressed in Escherichia coli
WO2001053324A3 (en) Novel haptotactic peptides
Morris et al. Kallikrein and renin: molecular biology and biosynthesis
Ikeuchi et al. Two new components of 9 and 14 kDa from spinach photosystem I complex